BRTX
NASDAQ · Biotechnology
Biorestorative Therapies Inc
$2.31
-0.24 (-9.41%)
Open$2.42
Previous Close$2.55
Day High$2.49
Day Low$2.29
52W High$34.60
52W Low$2.50
Volume—
Avg Volume27.8K
Market Cap3.52M
P/E Ratio—
EPS$-15.98
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,032.9% upside
Current
$2.31
$2.31
Target
$26.17
$26.17
$18.72
$26.17 avg
$39.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.09M | 757.3K | 1.76M |
| Net Income | -43,235,532 | -26,988,471 | 288.6K |
| Profit Margin | -3,959.4% | -3,761.4% | 16.4% |
| EBITDA | -46,863,747 | -30,878,457 | 503.0K |
| Free Cash Flow | — | — | 335.8K |
| Rev Growth | +44.2% | +44.2% | +14.5% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |